Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 656

    1.

    Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial.

    Rizkalla SW, Taghrid L, Laromiguiere M, Huet D, Boillot J, Rigoir A, Elgrably F, Slama G.

    Diabetes Care. 2004 Aug;27(8):1866-72.PMID: 15277409 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet.

    Sloth B, Krog-Mikkelsen I, Flint A, Tetens I, Björck I, Vinoy S, Elmståhl H, Astrup A, Lang V, Raben A.

    Am J Clin Nutr. 2004 Aug;80(2):337-47.PMID: 15277154 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men.

    Bouché C, Rizkalla SW, Luo J, Vidal H, Veronese A, Pacher N, Fouquet C, Lang V, Slama G.

    Diabetes Care. 2002 May;25(5):822-8.PMID: 11978675 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men.

    Kabir M, Oppert JM, Vidal H, Bruzzo F, Fiquet C, Wursch P, Slama G, Rizkalla SW.

    Metabolism. 2002 Jul;51(7):819-26.PMID: 12077724 [PubMed - indexed for MEDLINE]Related articles

    5.

    Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.

    Järvi AE, Karlström BE, Granfeldt YE, Björck IE, Asp NG, Vessby BO.

    Diabetes Care. 1999 Jan;22(1):10-8.PMID: 10333897 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A low-glycemic-index diet reduces plasma plasminogen activator inhibitor-1 activity, but not tissue inhibitor of proteinases-1 or plasminogen activator inhibitor-1 protein, in overweight women.

    Jensen L, Sloth B, Krog-Mikkelsen I, Flint A, Raben A, Tholstrup T, Brünner N, Astrup A.

    Am J Clin Nutr. 2008 Jan;87(1):97-105.PMID: 18175742 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes.

    Gerhard GT, Ahmann A, Meeuws K, McMurry MP, Duell PB, Connor WE.

    Am J Clin Nutr. 2004 Sep;80(3):668-73.PMID: 15321807 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Types of carbohydrate in an ordinary diet affect insulin action and muscle substrates in humans.

    Kiens B, Richter EA.

    Am J Clin Nutr. 1996 Jan;63(1):47-53.PMID: 8604670 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.

    Wolever TM, Gibbs AL, Mehling C, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

    Am J Clin Nutr. 2008 Jan;87(1):114-25.PMID: 18175744 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    An 18-mo randomized trial of a low-glycemic-index diet and weight change in Brazilian women.

    Sichieri R, Moura AS, Genelhu V, Hu F, Willett WC.

    Am J Clin Nutr. 2007 Sep;86(3):707-13.PMID: 17823436 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Beneficial effects of a 5-week low-glycaemic index regimen on weight control and cardiovascular risk factors in overweight non-diabetic subjects.

    de Rougemont A, Normand S, Nazare JA, Skilton MR, Sothier M, Vinoy S, Laville M.

    Br J Nutr. 2007 Dec;98(6):1288-98. Epub 2007 Jul 9.PMID: 17617942 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus.

    Sargrad KR, Homko C, Mozzoli M, Boden G.

    J Am Diet Assoc. 2005 Apr;105(4):573-80.PMID: 15800559 [PubMed - indexed for MEDLINE]Related articles

    14.

    Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.

    Luo J, Rizkalla SW, Vidal H, Oppert JM, Colas C, Boussairi A, Guerre-Millo M, Chapuis AS, Chevalier A, Durand G, Slama G.

    Diabetes Care. 1998 May;21(5):717-24.PMID: 9589230 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.
    16.

    Glycemic index, cholecystokinin, satiety and disinhibition: is there an unappreciated paradox for overweight women?

    Burton-Freeman BM, Keim NL.

    Int J Obes (Lond). 2008 Nov;32(11):1647-54. Epub 2008 Sep 30.PMID: 18825157 [PubMed - indexed for MEDLINE]Related articles

    17.

    Low-glycemic index foods improve long-term glycemic control in NIDDM.

    Brand JC, Colagiuri S, Crossman S, Allen A, Roberts DC, Truswell AS.

    Diabetes Care. 1991 Feb;14(2):95-101.PMID: 2060429 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients.

    Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D'Episcopo L, Riccardi G.

    Diabetes Care. 2000 Oct;23(10):1461-6.PMID: 11023137 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Diets high and low in glycemic index versus high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM.

    Luscombe ND, Noakes M, Clifton PM.

    Eur J Clin Nutr. 1999 Jun;53(6):473-8.PMID: 10403584 [PubMed - indexed for MEDLINE]Related articles

    20.

    Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.

    Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB.

    Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7.PMID: 11477493 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data